FDA Shares Drug-Making Lessons: Workshop Seeks Feedback
Published Date: 8/19/2025
Notice
Summary
The FDA is hosting a virtual workshop to share what they’ve learned from a special pilot program that helps speed up the chemistry and manufacturing steps for new drugs. This affects drug makers and patients waiting for faster access to promising treatments. The workshop will gather feedback to improve future policies, aiming to make drug development quicker and smoother without extra costs or delays.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FDA Workshop on Speeding Drug Manufacturing
The FDA is hosting a virtual public workshop called the CMC Development and Readiness Pilot (CDRP) Lessons Learned meeting to share sponsor and Agency experience under the pilot and to collect feedback. The workshop will solicit input on future FDA policy and programs to help facilitate expedited chemistry, manufacturing, and controls (CMC) development of products under an investigational new drug application (IND).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in